menu search

Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data

November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Aligos Therapeu...

November 3, 2023, 8:30 pm

November 2023 letter to shareholders

VANCOUVER, Washington, Nov. 03, 2023 (GLOBE NEWSWIRE) — Dear Shareholders, We write to provide an update on CytoDyn Inc. (“CytoDyn” or “Compan...

November 3, 2023, 8:02 pm

New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023

Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) — Opus Genetics, a patient-focu...

November 3, 2023, 7:43 pm

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS disease...

November 3, 2023, 7:41 pm

Longeveron to report third quarter 2023 results and provide corporate update on november 10, 2023

MIAMI, Nov. 03, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company <...

November 3, 2023, 12:00 pm

Astria therapeutics to present new star-0215 data at the 2023 american college of allergy, asthma, and immunology annual scientific meeting

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on devel...

November 3, 2023, 8:10 am

Sealsq raises fy 2023 revenue guidance to approximately $30 million, up by 29% as compared to fy 2022

Growth fueled by robust demand for advanced semiconductors and Matter certification services Tortola, British Virgin Islands, Nov. 03, 2023 (GLOBE NEW...

November 3, 2023, 5:00 am

Moto g power 5g cad renders tip design from every angle

Motorola has already unveiled the Moto G Power 5G to the U.S. market, but now the company is said to be working on ...

November 3, 2023, 1:29 am

Alexandria real estate: a fast-growing and fairly valued reit

Alexandria Real Estate Equities specializes in developing Class A/A+ properties for the life science, a...

November 2, 2023, 8:15 pm

Cidara therapeutics provides corporate update and reports third quarter 2023 financial results

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on ...

November 2, 2023, 8:15 pm

Ocugen to host conference call on thursday, november 9 at 8:30 a.m. et to discuss business updates and third quarter 2023 financial results

MALVERN, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, ...

November 2, 2023, 11:30 am

In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company ...

November 2, 2023, 9:17 am

Molecular partners to present initial data from ongoing phase 1/2a trial of mp0533 for patients with relapsed/refractory aml and aml/mds at the 65th ash annual meeting and exposition

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (...

November 2, 2023, 2:00 am

Hillevax to present at upcoming investor conferences

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on ...

November 1, 2023, 4:48 pm

Gracell biotechnologies to participate in four upcoming investor conferences

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDA...

November 1, 2023, 4:00 pm

Processa pharmaceuticals announces formation of oncology advisory board with renowned key opinion leaders

Company To Leverage World-Class Oncology Advisory Board in the Design of Oncology Trial Protocols, Including the Anticipated Phase 2 Trial for NGC-Cap...

November 1, 2023, 12:15 pm

Masonic cancer center, university of minnesota to present data in poster presentation human data readout for phase 1 study to evaluate hcw9218 in solid tumors at sitc 38th annual meeting

HCW9218 is the lead product candidate of HCW Biologics Inc. MIRAMAR, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or...

November 1, 2023, 11:30 am

Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 ctos annual meeting

– Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools –...

November 1, 2023, 10:30 am

Tearsolutions, inc. appoints robert dempsey to its board of directors

Dempsey brings worldwide Ophthalmology leadership experience in driving successful drug development CHARLOTTESVILLE, Va., Nov. 01, 2023 (GLOBE NEWSWIR...

November 1, 2023, 10:00 am

Zymeworks announces participation in upcoming investor conferences

VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company ...

November 1, 2023, 8:30 am


Search within

Pages Search Results: